A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4
Journal
Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
14
07
2021
accepted:
19
01
2022
revised:
10
01
2022
pubmed:
17
2
2022
medline:
28
4
2022
entrez:
16
2
2022
Statut:
ppublish
Résumé
Immunosuppressive Interleukin (IL)-10 production by pro-inflammatory CD4
Identifiants
pubmed: 35169232
doi: 10.1038/s41385-022-00487-x
pii: S1933-0219(22)00069-1
pmc: PMC9038525
doi:
Substances chimiques
Maf protein, mouse
0
Proto-Oncogene Proteins c-maf
0
STAT3 Transcription Factor
0
STAT3 protein, human
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
480-490Informations de copyright
© 2022. The Author(s).
Références
Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O’Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001).
pubmed: 11244051
doi: 10.1146/annurev.immunol.19.1.683
Neumann, C., Scheffold, A. & Rutz, S. Functions and regulation of T cell-derived interleukin-10. Semin Immunol. 44, 101344 (2019).
pubmed: 31727465
doi: 10.1016/j.smim.2019.101344
Engelhardt, K. R. & Grimbacher, B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr. Top. Microbiol Immunol. 380, 1–18 (2014).
pubmed: 25004811
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993).
pubmed: 8402911
doi: 10.1016/0092-8674(93)80068-P
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71–109 (2011).
pubmed: 21166540
doi: 10.1146/annurev-immunol-031210-101312
Roers, A. et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med 200, 1289–1297 (2004).
pubmed: 15534372
pmcid: 2211912
doi: 10.1084/jem.20041789
Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
pubmed: 18387831
doi: 10.1016/j.immuni.2008.02.017
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med 190, 995–1004 (1999).
pubmed: 10510089
pmcid: 2195650
doi: 10.1084/jem.190.7.995
Vieira, P. L. et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986–5993 (2004).
pubmed: 15128781
doi: 10.4049/jimmunol.172.10.5986
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M. & Gagliani, N. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49, 1004–1019 (2018).
pubmed: 30566879
doi: 10.1016/j.immuni.2018.12.001
Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
pubmed: 9338786
doi: 10.1038/39614
Jankovic, D. et al. Conventional T-bet(+)Foxp3(−) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med 204, 273–283 (2007).
pubmed: 17283209
pmcid: 2118735
doi: 10.1084/jem.20062175
Anderson, C. F., Oukka, M., Kuchroo, V. J. & Sacks, D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med 204, 285–297 (2007).
pubmed: 17283207
pmcid: 2118728
doi: 10.1084/jem.20061886
Jankovic, D., Kugler, D. G. & Sher, A. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 3, 239–246 (2010).
pubmed: 20200511
pmcid: 4105209
doi: 10.1038/mi.2010.8
Trinchieri, G. Interleukin-10 production by effector T cells: Th1 cells show self control. J. Exp. Med 204, 239–243 (2007).
pubmed: 17296790
pmcid: 2118719
doi: 10.1084/jem.20070104
O’Garra, A. & Vieira, P. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7, 425–428 (2007).
pubmed: 17525751
doi: 10.1038/nri2097
Saraiva, M. et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209–219 (2009).
pubmed: 19646904
pmcid: 2791889
doi: 10.1016/j.immuni.2009.05.012
Chang, H. D. et al. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37, 807–817 (2007).
pubmed: 17304625
doi: 10.1002/eji.200636385
McGeachy, M. J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).
pubmed: 17994024
doi: 10.1038/ni1539
Spolski, R., Kim, H. P., Zhu, W., Levy, D. E. & Leonard, W. J. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182, 2859–2867 (2009).
pubmed: 19234181
doi: 10.4049/jimmunol.0802978
Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967–971 (2010).
pubmed: 20962846
pmcid: 3108066
doi: 10.1038/nature09447
Batten, M. et al. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180, 2752–2756 (2008).
pubmed: 18292493
doi: 10.4049/jimmunol.180.5.2752
Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363–1371 (2007).
pubmed: 17994025
doi: 10.1038/ni1537
Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380–1389 (2007).
pubmed: 17994022
doi: 10.1038/ni1541
Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797–801 (2009).
pubmed: 19570826
doi: 10.4049/jimmunol.0901233
Fitzgerald, D. C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372–1379 (2007).
pubmed: 17994023
doi: 10.1038/ni1540
Zhang, H. et al. An IL-27-driven transcriptional network identifies regulators of IL-10 expression across T helper cell subsets. Cell Rep. 33, 108433 (2020).
pubmed: 33238123
pmcid: 7771052
doi: 10.1016/j.celrep.2020.108433
Levings, M. K. et al. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530–5539 (2001).
pubmed: 11313392
doi: 10.4049/jimmunol.166.9.5530
Ziegler-Heitbrock, L. et al. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J. Immunol. 171, 285–290 (2003).
pubmed: 12817009
doi: 10.4049/jimmunol.171.1.285
Aman, M. J. et al. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 87, 4731–4736 (1996).
pubmed: 8639843
doi: 10.1182/blood.V87.11.4731.bloodjournal87114731
Corre, B. et al. Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4(+) T cells. Eur. J. Immunol. 43, 2730–2740 (2013).
pubmed: 23839924
doi: 10.1002/eji.201242977
Rutz, S. et al. Notch regulates IL-10 production by T helper 1 cells. Proc. Natl Acad. Sci. USA 105, 3497–3502 (2008).
pubmed: 18292228
pmcid: 2265185
doi: 10.1073/pnas.0712102105
Kassner, N. et al. Cutting edge: plasmacytoid dendritic cells induce IL-10 production in T cells via the delta-like-4/Notch axis. J. Immunol. 184, 550–554 (2010).
pubmed: 20008296
doi: 10.4049/jimmunol.0903152
Neumann, K. et al. Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway. Eur. J. Immunol. 45, 2008–2016 (2015).
pubmed: 25884798
doi: 10.1002/eji.201445346
Neumann, C. et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med 211, 1807–1819 (2014).
pubmed: 25073792
pmcid: 4144744
doi: 10.1084/jem.20131548
Imbratta, C., Hussein, H., Andris, F. & Verdeil, G. c-MAF, a swiss army knife for tolerance in lymphocytes. Front Immunol. 11, 206 (2020).
pubmed: 32117317
pmcid: 7033575
doi: 10.3389/fimmu.2020.00206
Gabrysova, L. et al. c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells. Nat. Immunol. 19, 497–507 (2018).
pubmed: 29662170
pmcid: 5988041
doi: 10.1038/s41590-018-0083-5
Neumann, C. et al. c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host-microbiota homeostasis. Nat. Immunol. 20, 471–481 (2019).
pubmed: 30778241
doi: 10.1038/s41590-019-0316-2
Parish, I. A. et al. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1. J. Clin. Invest 124, 3455–3468 (2014).
pubmed: 25003188
pmcid: 4109559
doi: 10.1172/JCI66108
Iwasaki, Y. et al. Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells. Eur. J. Immunol. 43, 1063–1073 (2013).
pubmed: 23349024
doi: 10.1002/eji.201242942
Xu, J. et al. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182, 6226–6236 (2009).
pubmed: 19414776
doi: 10.4049/jimmunol.0900123
Martins, G. A. et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat. Immunol. 7, 457–465 (2006).
pubmed: 16565721
doi: 10.1038/ni1320
Cretney, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304–311 (2011).
pubmed: 21378976
doi: 10.1038/ni.2006
Aschenbrenner, D. et al. An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells. Nat. Immunol. 19, 1126–1136 (2018).
pubmed: 30201991
pmcid: 6402560
doi: 10.1038/s41590-018-0200-5
Perucha, E. et al. The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells. Nat. Commun. 10, 498 (2019).
pubmed: 30700717
pmcid: 6353904
doi: 10.1038/s41467-019-08332-9
Jin, J. O., Han, X. & Yu, Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J. Autoimmun. 40, 28–44 (2013).
pubmed: 22921334
doi: 10.1016/j.jaut.2012.07.009
Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F. & Campbell, D. J. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119, 4430–4440 (2012).
pubmed: 22438251
pmcid: 3362361
doi: 10.1182/blood-2011-11-392324
Tu, L. et al. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med 202, 1037–1042 (2005).
pubmed: 16230473
pmcid: 2213210
doi: 10.1084/jem.20050923
Kamali, A. N. et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol. Immunol. 105, 107–115 (2019).
pubmed: 30502718
doi: 10.1016/j.molimm.2018.11.015
Anderson, A. C., Joller, N. & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity 44, 989–1004 (2016).
pubmed: 27192565
pmcid: 4942846
doi: 10.1016/j.immuni.2016.05.001
Gagliani, N. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med 19, 739–746 (2013).
pubmed: 23624599
doi: 10.1038/nm.3179
Gabrysova, L., Howes, A., Saraiva, M. & O’Garra, A. The regulation of IL-10 expression. Curr. Top. Microbiol Immunol. 380, 157–190 (2014).
pubmed: 25004818
Saraiva, M. & O’Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170–181 (2010).
pubmed: 20154735
doi: 10.1038/nri2711
Benson, R. A. et al. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production. Eur. J. Immunol. 35, 859–869 (2005).
pubmed: 15688350
doi: 10.1002/eji.200425562
Le Friec, G. et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat. Immunol. 13, 1213–1221 (2012).
pubmed: 23086448
pmcid: 3505834
doi: 10.1038/ni.2454
Mitchell, R. E. et al. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. Sci. Rep. 7, 11315 (2017).
pubmed: 28900244
pmcid: 5595963
doi: 10.1038/s41598-017-11803-y
Avalle, L., Pensa, S., Regis, G., Novelli, F. & Poli, V. STAT1 and STAT3 in tumorigenesis: A matter of balance. JAKSTAT 1, 65–72 (2012).
pubmed: 24058752
pmcid: 3670295
Regis, G., Pensa, S., Boselli, D., Novelli, F. & Poli, V. Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev. Biol. 19, 351–359 (2008).
pubmed: 18620071
doi: 10.1016/j.semcdb.2008.06.004
Qing, Y. & Stark, G. R. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J. Biol. Chem. 279, 41679–41685 (2004).
pubmed: 15284232
doi: 10.1074/jbc.M406413200
Wan, C. K. et al. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells. Proc. Natl Acad. Sci. USA 112, 9394–9399 (2015).
pubmed: 26170288
pmcid: 4522759
doi: 10.1073/pnas.1511711112
Hong, F. et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest 110, 1503–1513 (2002).
pubmed: 12438448
pmcid: 151811
doi: 10.1172/JCI0215841
Murano, T. et al. Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells. Biochem Biophys. Res. Commun. 443, 840–846 (2014).
pubmed: 24342613
doi: 10.1016/j.bbrc.2013.12.061
Zhou, X. et al. Hes1 desynchronizes differentiation of pluripotent cells by modulating STAT3 activity. Stem Cells 31, 1511–1522 (2013).
pubmed: 23649667
pmcid: 4063271
doi: 10.1002/stem.1426
Kamakura, S. et al. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6, 547–554 (2004).
pubmed: 15156153
doi: 10.1038/ncb1138
Zhang, P. et al. Eomesodermin promotes the development of type 1 regulatory T (TR1) cells. Sci. Immunol. 2, https://doi.org/10.1126/sciimmunol.aah7152 (2017).
Gruarin, P. et al. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-gamma coproducing regulatory T cells. Eur. J. Immunol. 49, 96–111 (2019).
pubmed: 30431161
doi: 10.1002/eji.201847722
Bonnal, R. J. P. et al. Clonally expanded EOMES(+) Tr1-like cells in primary and metastatic tumors are associated with disease progression. Nat. Immunol. 22, 735–745 (2021).
pubmed: 34017124
doi: 10.1038/s41590-021-00930-4
Yadava, K. et al. Natural Tr1-like cells do not confer long-term tolerogenic memory. Elife 8, https://doi.org/10.7554/eLife.44821 (2019).
Alfen, J. S. et al. Intestinal IFN-gamma-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. J. Allergy Clin. Immunol. 142, 1537–1547 e1538 (2018).
pubmed: 29369775
doi: 10.1016/j.jaci.2017.12.984
Brockmann, L. et al. Molecular and functional heterogeneity of IL-10-producing CD4(+) T cells. Nat. Commun. 9, 5457 (2018).
pubmed: 30575716
pmcid: 6303294
doi: 10.1038/s41467-018-07581-4
Chihara, N. et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558, 454–459 (2018).
pubmed: 29899446
pmcid: 6130914
doi: 10.1038/s41586-018-0206-z
Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
pubmed: 23128233
pmcid: 3491803
doi: 10.1038/nature11582
Zhang, J. et al. Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: a meta-analysis. PLoS One 9, e109625 (2014).
pubmed: 25286337
pmcid: 4186844
doi: 10.1371/journal.pone.0109625
Ellinghaus, D. et al. Association between variants of PRDM1 and NDP52 and Crohn’s disease, based on exome sequencing and functional studies. Gastroenterology 145, 339–347 (2013).
pubmed: 23624108
doi: 10.1053/j.gastro.2013.04.040
Galvez, J. Role of Th17 cells in the pathogenesis of human IBD. ISRN Inflamm. 2014, 928461 (2014).
pubmed: 25101191
pmcid: 4005031
doi: 10.1155/2014/928461
Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. Natl. Acad. Sci. USA 112, 7061–7066 (2015).
pubmed: 26038559
pmcid: 4460486
doi: 10.1073/pnas.1415675112
Monteleone, I., Pallone, F. & Monteleone, G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med. 9, 122 (2011).
pubmed: 22082127
pmcid: 3239315
doi: 10.1186/1741-7015-9-122
Giles, E. M. et al. Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease. Mucosal. Immunol. 10, 184–193 (2017).
pubmed: 27220814
doi: 10.1038/mi.2016.44